Abstract
To provide an integrin binding peptide that is particularly ITGA5, ITGA11, α5β1 integrin and an α11β1 binding peptide.SOLUTION: An integrin binding peptide, a pharmaceutical composition containing a peptide thereof, and use thereof as a therapeutic agent, a diagnostic agent, an imaging agent, and a targeting agent.SELECTED DRAWING: None
Original language | English |
---|---|
Patent number | JP2023093473 |
IPC | G01N 33/ 53 A I |
Priority date | 23/03/21 |
Publication status | Published - 4 Jul 2023 |